{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-25-000145","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.436459+00:00","generated_at":"2026-05-18T21:53:39.985603+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NeoGenomics appoints Merck oncology head Dr. Marjorie Green to board","bullets":["Dr. Marjorie C. Green appointed to NeoGenomics board effective June 19, 2025; board expands from 9 to 10 members.","Dr. Green is SVP and Head of Oncology, Global Clinical Development at Merck, leading oncology R&D for Merck's largest revenue area.","Prior leadership roles include SVP Late-Stage Development at Seagen and VP at Genentech; began career as medical oncologist at MD Anderson.","She will serve as an independent director until the 2026 annual meeting; compensation follows standard director program."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-25-000145","json":"https://secwatch.observer/filing/0001077183-25-000145.json","markdown":"https://secwatch.observer/filing/0001077183-25-000145.md","text":"https://secwatch.observer/filing/0001077183-25-000145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000145/0001077183-25-000145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000145/neo-20250619.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T21:53:39.985603+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b1151c000","claim":"Marjorie C. Green was appointed as Director at NEOGENOMICS INC.","evidence_excerpt":"On June 19, 2025, the Board of Directors of NeoGenomics, Inc. (the \"Company\") increased the size of the Board of Directors (the \"Board\") from nine to ten members and appointed Marjorie C. Green as a director to fill the vacancy resulting from that increase.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000145/0001077183-25-000145-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}